VEGFA and lung carcinoma: Surgery, radiation therapy, and chemotherapy using tumor specific targeted agents such as vascular endothelial growth factor (VEGF) inhibitor bevacizumab and epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR TKIs) are the primary tools for treating lung cancer.